idverde group, specialists in the creation and landscaping of green spaces with more than 8’000 employees and branches in France, the United Kingdom, the Netherlands, Denmark and Germany, is now extending its activities to Switzerland where
Following the Spin-off, Sulzer and Medmix shares will start trading separately on the SIX Swiss Exchange. In an offering of new shares, which took place at the same time, 7 million new shares were issued in
Cosmo Pharmaceuticals and Cassiopea have entered into a transaction agreement under which Cosmo is launching a public exchange offer in Switzerland to acquire all of the publicly-held registered shares of Cassiopea. The public exchange offer
Archlet, an AI-based sourcing platform startup and ETH Zürich spin-off, just closed its USD 10M Series A Financing Round. The round was led by the European venture capitalist HV Capital. The existing investors, including
Ringier Axel Springer Schweiz, the media production company, is expanding its Services division and has acquired Gryps Offertenportal, a company specialised in procuring products and services for SMEs, from its founders and further shareholders. The
Swiss Prime Site Solutions, a real estate asset management company, received final confirmation from the Swiss Financial Market Supervisory Authority FINMA of its authorisation as a fund management company under the Financial Institutions Act. The
Alpora, a Swiss investment analytics company, has sold a majority stake to German-based Serafin Asset Management. Alpora, which was founded in 2013, is active in the sale of innovation analysis-based investment models to asset managers in
Nater Dallafior advised and represented a Swiss-domiciled company – being the policyholder – against its insurer in connection with the policyholder’s claim for coverage based on a business interruption insurance policy. The policyholder is active in
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
The persistent low interest rate environment over the past few years has prompted changes in the life insurance industry. Against this backdrop, Allianz Suisse Lebensversicherungs-Gesellschaft and the reinsurance company Resolution Re have agreed on an
